Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
J Surg Case Rep ; 2022(8): rjac375, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36003221

ABSTRACT

Thymoma is a rare tumour that often occurs in the anterior mediastinum. Thymomas are usually diagnosed in middle-aged patients, and nearly half of cases are associated with myasthenia gravis. Thymomas typically progress through direct invasion of the thoracic cavity with extra-thoracic distant metastasis being uncommon. Here we report the case of a male patient who underwent an extensive thymectomy and radiotherapy 10 years before presentation, and in whom we detected a spleen tumour during regular out-patient follow-up. The patient underwent a splenectomy, and a final diagnosis of type B3 malignant thymoma was established.

3.
Surgery ; 155(2): 320-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24035616

ABSTRACT

BACKGROUND: The parathyroidectomy assessment of symptoms (PAS) score was designed initially for primary hyperparathyroidism to provide a specific symptom assessment and was validated later in secondary and tertiary hyperparathyroidism. The aim of our study was to evaluate changes in the PAS scores and quality of life before and after parathyroidectomy for secondary hyperparathyroidism. METHODS: This prospective study included 49 consecutive patients who underwent parathyroidectomy for secondary hyperparathyroidism. The PAS and Short Form (SF)-36 questionnaires were completed before parathyroidectomy and at 12 months postoperatively. RESULTS: All 13 symptoms included in the PAS score improved significantly. The mean ± standard deviation PAS score decreased from 545 ± 263 to 284 ± 201 (P < .0001) after parathyroidectomy. Quality of life was enhanced in both physical (40.3 ± 17.1 to 59.0 ± 14.9; P < .0001) and mental (47.6 ± 17.1 to 63.7 ± 13.0; P < .0001) components. The PAS score was inversely correlated with the SF-36 global score preoperatively and postoperatively (r(2) = 0.48 and 0.25; P < .001). The change in PAS score also correlated with the change in SF-36 global score (r(2) = 0.29; P < .001). Multiple linear regression analysis showed that preoperative PAS score and bone mineral density T-score were predictors of the decrease in PAS score. Preoperative SF-36 global score and intact parathyroid hormone levels were predictors of the increment in SF-36 score. CONCLUSION: The symptom burden of secondary hyperparathyroidism has a negative impact on a patient's quality of life. Parathyroidectomy is associated with a marked improvement in symptoms and quality of life.


Subject(s)
Hyperparathyroidism, Secondary/surgery , Parathyroidectomy , Adult , Aged , Female , Humans , Male , Middle Aged , Prospective Studies , Quality of Life , Regression Analysis , Treatment Outcome , Young Adult
4.
Anticancer Res ; 33(12): 5543-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24324095

ABSTRACT

BACKGROUND: The current study aimed to examine the impact of zoledronic acid therapy on health-related quality of life (HRQoL) in Taiwanese patients with bone metastases from breast cancer. PATIENTS AND METHODS: Patients with bone metastases from breast cancer who received zoledronic acid according to the standards of care were enrolled in this observational phase IV study. HRQoL was measured monthly using the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (QLQ-C30) and the breast cancer-specific module (BR-23) for 24 months. RESULTS: A total of 366 patients from 13 centers were enrolled. QLQ C-30 demonstrated that zoledronic acid improved the HRQoL in different aspects. In particular, a significant reduction of pain in the first 14 months and the 22-month follow-up was reported by patients. QLQ-BR23 indicated improved future perspective and breast symptom scores over the course of the study. CONCLUSION: These data confirm the HRQoL benefits and safety of zoledronic acid in Taiwanese patients with bone metastases from breast cancer.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Bone Neoplasms/drug therapy , Breast Neoplasms/physiopathology , Diphosphonates/therapeutic use , Imidazoles/therapeutic use , Quality of Life , Adult , Bone Neoplasms/secondary , Breast Neoplasms/pathology , Breast Neoplasms/psychology , Female , Humans , Middle Aged , Taiwan , Zoledronic Acid
5.
J Surg Res ; 168(1): 82-7, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-19932904

ABSTRACT

OBJECTIVE: Female gender is associated with an increased risk of parathyroid nodular hyperplasia and parathyroidectomy rate in dialysis patients. The purpose of this study was to assess differences between women and men undergoing parathyroidectomy for secondary hyperparathyroidism. METHODS: We reviewed 121 consecutive patients with end-stage renal disease and advanced secondary hyperparathyroidism who underwent parathyroidectomy between 2004 and 2007. Preoperative characteristics and short-term outcome of these patients were evaluated. RESULTS: Compared with men (n = 43), women (n = 78) had lower preoperative bone mineral density (both T-scores and Z-scores) as well as lower preoperative hemoglobin levels. The cause of renal failure was also different between the two groups. No differences in preoperative calcium-phosphorus product, alkaline phosphatase, or parathyroid hormone levels were observed. Follow-up analysis showed that biochemical improvement and 1-y recurrence rate was similar between genders. CONCLUSION: Women with secondary hyperparathyroidism had worse bone mineral metabolism before parathyroidectomy. Additional research regarding target organ susceptibility to hyperparathyroidism in different genders is warranted.


Subject(s)
Hyperparathyroidism, Secondary/surgery , Parathyroidectomy , Sex Characteristics , Adolescent , Adult , Aged , Bone Density , Female , Hemoglobins/metabolism , Humans , Hyperparathyroidism, Secondary/metabolism , Male , Middle Aged , Parathyroid Hormone/metabolism , Prospective Studies , Recurrence , Retrospective Studies , Treatment Outcome , Young Adult
6.
Med Oncol ; 28(1): 159-62, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20107932

ABSTRACT

Desmoid tumor originating from the small intestine is extremely rare. We report a 50-year-old man who presented with the sudden onset of severe abdominal pain. Computerized tomography (CT) demonstrated a huge homogeneous tumor in the lower abdomen that appeared to be in continuity with the distal ileum. The mass adherent to the ileum was resected and proved to be a desmoid tumor. The patient has remained recurrence free on follow-up.


Subject(s)
Fibromatosis, Abdominal/pathology , Intestinal Neoplasms/pathology , Intestine, Small/pathology , Fibromatosis, Abdominal/surgery , Humans , Intestinal Neoplasms/surgery , Intestine, Small/surgery , Male , Middle Aged , Tomography, X-Ray Computed
7.
Surgery ; 147(6): 847-53, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20045163

ABSTRACT

BACKGROUND: Epidemiologic studies have shown that obesity is associated with an increased risk of thyroid cancer. Leptin, an adipocyte-derived cytokine, can act as a growth factor on certain normal and transformed cells. Aberrant expression of leptin or leptin receptor has been detected in some types of cancer. The aim of this study is to determine immunohistochemical expression of leptin and leptin receptor in papillary thyroid cancer to investigate the relationship between their expression and clinicopathologic features. METHODS: The expression of leptin and leptin receptor was assessed in 49 primary neoplasms and 15 lymph node metastases using a semiquantitative immunohistochemical staining method. RESULTS: Leptin and leptin receptor were expressed in 37% and 51% of papillary thyroid cancer, respectively. They were not expressed in normal follicles. In the primary neoplasms and the metastatic nodes, expression of leptin correlated closely with leptin receptor (P < .001 for the primary neoplasms and P = .017 for nodal metastases). Expression of either protein was associated with greater neoplasm size (leptin expression, 32.0 +/- 10.7 vs 20.5 +/- 8.4 mm; P = .001; leptin receptor expression, 27.9 +/- 11.5 vs 21.4 +/- 9.0 mm; P = .032). Coexpression of leptin and leptin receptor in primary neoplasms had greater incidence of lymph node metastasis (P = .038). CONCLUSION: Expression of leptin and/or leptin receptor in papillary thyroid cancer is associated with neoplasm aggressiveness, including tumor size and lymph node metastasis.


Subject(s)
Carcinoma, Papillary/genetics , Carcinoma, Papillary/surgery , Leptin/genetics , Receptors, Leptin/genetics , Thyroid Neoplasms/genetics , Thyroid Neoplasms/surgery , Adult , Body Mass Index , Carcinoma, Papillary/metabolism , Carcinoma, Papillary/pathology , Female , Humans , Immunohistochemistry , Leptin/metabolism , Lymphatic Metastasis/genetics , Lymphatic Metastasis/pathology , Male , Middle Aged , Receptors, Leptin/metabolism , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/pathology
8.
World J Surg ; 33(1): 72-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18953601

ABSTRACT

BACKGROUND: Protracted hypocalcemia is the most common complication after parathyroidectomy for secondary hyperparathyroidism. Several parameters have been identified to predict the degree of postoperative hypocalcemia. The purpose of this study was to determine whether there were any factors associated with prolonged hospitalization in these patients. METHODS: A total of 81 consecutive patients with end-stage renal disease and advanced secondary hyperparathyroidism who underwent parathyroidectomy between January 2004 and December 2006 were studied. The postoperative calcium infusion protocol and discharge criteria were standardized. Clinical variables were compared between patients with a shorter or longer postoperative stay. RESULTS: The mean postoperative hospital stay was 5.6 days. Preoperative alkaline phosphatase levels were significantly higher in patients with a longer stay (p=0.035). In a linear regression model, the postoperative length of stay was moderately but significantly correlated with preoperative alkaline phosphatase levels (R2=0.254; p<0.001). Receiver operating characteristic analysis showed a significant area under the curve (0.678; 95% confidence interval 0.550-0.805; p=0.014). With a cutoff of preoperative alkaline phosphatase levels at 200 IU/L, the sensitivity was 0.57 and the specificity was 0.59 for predicting a prolonged stay. CONCLUSIONS: A high preoperative alkaline phosphatase level is significantly associated with prolonged hospital stay in patients undergoing parathyroidectomy for secondary hyperparathyroidism.


Subject(s)
Alkaline Phosphatase/blood , Hyperparathyroidism, Secondary/surgery , Length of Stay , Parathyroidectomy/adverse effects , Adult , Aged , Biomarkers/blood , Female , Humans , Hyperparathyroidism, Secondary/complications , Kidney Failure, Chronic/complications , Male , Middle Aged , Postoperative Period , Preoperative Care/methods , ROC Curve , Retrospective Studies
9.
Am J Surg ; 196(4): e33-4, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18585675

ABSTRACT

Hyperplasia of Brunner's glands is a benign lesion discovered incidentally in 2% of upper gastrointestinal endoscopies. An asymptomatic 34-year-old woman had a 12-cm duodenal lesion resembling an elephant's proboscis. It was removed surgically and proved to be Brunner's gland hyperplasia.


Subject(s)
Brunner Glands/pathology , Brunner Glands/surgery , Duodenal Diseases/pathology , Duodenal Diseases/surgery , Duodenoscopy , Adult , Diagnosis, Differential , Female , Humans
10.
Am J Surg ; 196(2): 155-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18513687

ABSTRACT

BACKGROUND: Although percutaneous ethanol injection therapy (PEIT) is an alternative to surgery for patients with secondary or tertiary hyperparathyroidism, it also has been conjectured to make subsequent parathyroidectomy more difficult. METHODS: The records of 37 patients with end-stage renal disease managed between September 2000 and August 2005 were reviewed retrospectively. All patients had hyperparathyroidism intractable to medical treatment, and all eventually underwent parathyroidectomy. Of the 37 patients, 20 initially underwent PEIT, whereas 17 did not. Surgical and biochemical outcomes were compared between the 2 groups. RESULTS: i-PTH and biochemical markers before and after surgery did not differ significantly between the 2 groups, nor did the outcome, defined as persistent hypocalcemia, persistent hyperphosphatemia, persistent low or high i-PTH, persistent hoarseness, or residual parathyroid mass. Parathyroidectomy in the PEIT group proceeded smoothly and was not hindered by inflammation or tissue adhesion. CONCLUSIONS: Using PEIT to treat hyperparathyroidism in patients with end-stage renal disease does not make subsequent parathyroidectomy more difficult.


Subject(s)
Ethanol/administration & dosage , Hyperparathyroidism, Secondary/therapy , Parathyroidectomy , Solvents/administration & dosage , Biomarkers/blood , Calcium/blood , Drug Resistance , Female , Humans , Hyperparathyroidism, Secondary/etiology , Injections, Intralesional , Kidney Failure, Chronic/complications , Male , Middle Aged , Parathyroid Hormone/blood , Phosphates/blood , Retrospective Studies , Treatment Outcome
11.
Langenbecks Arch Surg ; 393(5): 729-32, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18404277

ABSTRACT

BACKGROUND: The likelihood of thyroid cancer is similar in patients with one or more nodules, but tumor characteristics of thyroid cancer in glands with multinodular goiter are unclear. MATERIALS AND METHODS: This study consisted of 100 consecutive patients (ages 15-81 years; 84 women), who underwent thyroidectomy for papillary or follicular thyroid carcinoma between 2005 and 2006. Patient demographics, diagnostic tests, operations, and pathological findings were reviewed. RESULTS: In a univariate analysis, cancer diagnosed within multinodular goiter was different from solitary cancer nodule in age of diagnosis (48 vs 40 years, p = 0.002), tumor size (1.42 vs 2.20 cm, p = 0.024), and the presence of cervical lymph node metastases (p = 0.035). There was no difference in gender, extrathyroidal invasion, multifocality, and types of operation. Only age (odds ratio, 1.056) and tumor size (odds ratio, 0.730) revealed independent correlation in multivariate analysis. CONCLUSION: Thyroid cancer in glands with multiple nodules is associated with older age at diagnosis and smaller tumor size.


Subject(s)
Adenocarcinoma, Follicular/pathology , Carcinoma, Papillary/pathology , Goiter, Nodular/pathology , Thyroid Neoplasms/pathology , Adenocarcinoma, Follicular/surgery , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Carcinoma, Papillary/surgery , Female , Goiter, Nodular/surgery , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Statistics as Topic , Thyroid Gland/pathology , Thyroid Neoplasms/surgery , Thyroidectomy , Young Adult
12.
Surg Endosc ; 22(5): 1283-9, 2008 May.
Article in English | MEDLINE | ID: mdl-17968623

ABSTRACT

BACKGROUND: Laparoscopic cholecystectomy in elderly patients has been linked to higher complication rates and longer lengths of stay. The purpose of this study was to identify risk factors associated with prolonged postoperative hospitalization in elderly patients undergoing laparoscopic cholecystectomy. METHODS: The records of 287 patients aged 65 years or older, who underwent successful laparoscopic cholecystectomy between January 2001 and July 2006, were retrospectively reviewed. Clinical data was abstracted from the chart and compared between patients with a shorter or longer postoperative stay. RESULTS: The median postoperative hospital stay was three days (interquartile range 3-5). Forty-eight patients had complications, with an overall morbidity of 16% and mortality of 0.7%. The only independent predictor of prolonged postoperative stay was the occurrence of any major complication [odds ratio, 3.144; 95% confidence interval (CI), 1.882-5.251]. The physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) and underlying chronic obstructive pulmonary disease were independently associated with major complications. CONCLUSIONS: A major complication is the most important cause of prolonged hospital stay after laparoscopic cholecystectomy in the elderly. No specific comorbidity has direct impact on the duration of hospitalization, but pulmonary disease is associated with increased risk of major complications.


Subject(s)
Cholecystectomy, Laparoscopic/statistics & numerical data , Length of Stay/statistics & numerical data , Aged , Aged, 80 and over , Cholecystectomy, Laparoscopic/adverse effects , Cholecystectomy, Laparoscopic/mortality , Comorbidity , Female , Gallstones/epidemiology , Gallstones/surgery , Humans , Male , Postoperative Complications , Postoperative Period , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/surgery , Retrospective Studies , Risk Factors , Treatment Outcome
13.
Oncology ; 72(1-2): 75-81, 2007.
Article in English | MEDLINE | ID: mdl-18004080

ABSTRACT

AIMS: We investigated the relationship between serum leptin concentrations and polymorphism of the leptin receptor gene and breast cancer. METHODS: Serum leptin concentrations were measured by enzyme-linked immunosorbent assay in 47 women with invasive breast cancer compared with 41 age-matched controls without cancer. Genomic DNA was extracted from peripheral blood leukocytes. Genotyping of the leptin receptor gene at codon 109 (LEPR-109) was performed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: Patients with breast cancer had a higher mean serum leptin concentration than women in the control group, but the difference was not statistically significant. Among those with breast cancer, the serum leptin concentration was higher in women with high-grade cancers (p = 0.020). The LEPR-109RR genotype was more frequent in premenopausal patients with tumors larger than 2 cm (p = 0.039) and in premenopausal women who were overweight (p = 0.029). Among patients with the LEPR-109RR genotype, higher mean serum leptin concentrations were present in those with triple-negative cancers (p = 0.048). CONCLUSIONS: Our study suggests an association between serum leptin concentration and tumor progression. LEPR-109 polymorphism in premenopausal women appears to be associated with obesity and tumor progression.


Subject(s)
Breast Neoplasms/blood , Breast Neoplasms/genetics , Leptin/blood , Receptors, Leptin/genetics , Adult , Case-Control Studies , Disease Progression , Female , Genotype , Humans , Middle Aged , Obesity , Polymorphism, Genetic , Premenopause
14.
J Formos Med Assoc ; 106(5): 392-6, 2007 May.
Article in English | MEDLINE | ID: mdl-17561474

ABSTRACT

Insulinoma in a patient with pre-existing diabetes is extremely rare. A 74-year-old woman with type 2 diabetes mellitus who had been treated with a sulfonylurea for 6 years began experiencing frequent episodes of hypoglycemia. Endogenous hyperinsulinism was found 9 months after the sulfonylurea was discontinued, and transabdominal ultrasonography and magnetic resonance imaging identified a pancreatic tumor. Pathology examination of the resected tumor demonstrated an insulinoma. Postoperatively, the patient had no further episodes of hypoglycemia. Thereafter, she required insulin to control her hyperglycemia. Although hypoglycemic agents are the commonest cause of hypoglycemia in type 2 diabetes, insulinomas may occur in these patients. This possibility should be considered if the hypoglycemia persists despite dose adjustment or cessation of the drugs.


Subject(s)
Diabetes Mellitus, Type 2/complications , Hypoglycemia/etiology , Insulinoma/complications , Insulinoma/diagnosis , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/diagnosis , Aged , Diabetes Mellitus, Type 2/drug therapy , Female , Gliclazide/therapeutic use , Humans , Hyperinsulinism/etiology , Hypoglycemic Agents/therapeutic use , Insulinoma/pathology , Insulinoma/surgery , Pancreas/diagnostic imaging , Pancreas/pathology , Pancreas/surgery , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery , Ultrasonography
15.
J Formos Med Assoc ; 106(3): 240-3, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17389169

ABSTRACT

Ectopic pancreas, an uncommon submucosal tumor in the gastrointestinal (GI) tract, is histologically similar to normal pancreatic tissue. We present a case of ectopic pancreas in the ileum. A 35-year-old man had intermittent dark bloody stool for 2 months accompanied by epigastric pain and postprandial abdominal fullness. Esophagogastroduodenoscopy and colonoscopy did not reveal any abnormalities. Capsule endoscopy revealed a small red polyp in the ileum. Abdominal computed tomography scan and small bowel barium follow-through study were not of any help. GI bleeding and abdominal discomfort were resolved after the lesion was surgically removed. Pathologic examination demonstrated pancreatic acinar cells and a secretory duct in the ileal submucosa, consistent with ectopic pancreas. Ectopic pancreas in the small intestine may be a rare cause of obscure GI bleeding. Capsule endoscopy seems to be a good, noninvasive tool for identification in the small bowel, particularly when other imaging modalities fail to detect any abnormalities.


Subject(s)
Choristoma/diagnosis , Endoscopy, Gastrointestinal/methods , Ileal Diseases/diagnosis , Pancreas , Adult , Choristoma/pathology , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Humans , Ileal Diseases/pathology , Male
16.
Food Chem Toxicol ; 45(6): 935-44, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17222494

ABSTRACT

Meclizine (MEC), a histamine H1 antagonist, is used for the treatment of motion sickness and vertigo. In this study, we demonstrate that MEC dose-dependently induced apoptosis in human colon cancer cell lines (COLO 205 and HT 29 cells). Results of a DNA ladder assay revealed that DNA ladders appeared with MEC treatment in COLO 205 cells at dosage of >50 microM. In addition, the total cell number decreased dose-dependently after treatment with MEC in COLO 205 and HT 29 cells. Using flow cytometry, the percentage of COLO 205 cells arrested at G0/G1 phase increased dose-dependently. Analysis of changes in cell-cycle arrest-associated proteins with Western blotting showed that p53 and p21 were upregulated after treatment with MEC. The kinase activities of cyclin-dependent kinase 2 (CDK2) and CDK4 were suppressed in MEC-treated cells. As for apoptosis, MEC may induce upregulation of p53 and downregulation of Bcl-2, thus causing the release of cytochrome C from mitochondria and the translocation of apoptosis-inducing factor (AIF) to the nucleus. This resulted in the activation of caspase 3, 8, and 9. Our results provide the molecular basis of MEC-induced apoptosis and cell-cycle arrest in human colon cancer cells.


Subject(s)
Apoptosis/drug effects , Cell Cycle/drug effects , Colonic Neoplasms/drug therapy , Meclizine/pharmacology , Apoptosis Inducing Factor/metabolism , Blotting, Western , Cell Cycle Proteins/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Colonic Neoplasms/pathology , Cyclin-Dependent Kinases/metabolism , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Flow Cytometry , HT29 Cells , Histamine H1 Antagonists/pharmacology , Humans
18.
J Surg Oncol ; 91(3): 185-94, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-16118768

ABSTRACT

BACKGROUND AND OBJECTIVES: Phyllodes tumors (PTs) are uncommon biphasic breast tumors that usually occur in adult females. They are composed of a benign epithelial component and a cellular, spindle cell stroma forming a leaf-like structure. No one morphologic finding is reliable in predicting the clinical behavior of the tumor. The purpose of this study was to explore the clinicopathologic factors associated with outcome and metastasis. METHODS: We retrospectively reviewed the records of 172 patients seen at Mackay Memorial Hospital from January 1985 to December 2003. Clinical data analyzed included age, presenting symptoms and signs, tumor size, location, type of surgery, time to recurrence, and metastasis. The clinicopathologic factors associated with outcome and metastasis were analyzed statistically using the chi-square test with Yate correction. RESULTS: The mean follow-up was 71 months (range 7-237). The mean age was 37 years (range 11-73). The majority of tumors were found in the upper outer quadrant (46.0%), with an equal propensity to occur in either breast (48.8% vs. 50.0%). The pathologic diagnoses included 131 benign, 12 borderline, and 29 malignant lesions. Nineteen patients (11%) had a recurrence and three (1.7%) had metastases. The initial diagnosis of all 19 recurrent tumors were benign. Age, surgical approach, mitotic activity, and surgical margin were significantly correlated with recurrence (P = 0.029, 0.020, 0.048, and 0.00018, respectively). Stromal cellularity, stromal overgrowth, stromal atypia, mitotic activity, tumor margin, and heterologous stromal elements were significantly correlated with metastases (P = 0.032, 0.00008, 0.000002, 0.004, 0.005, and 0.046, respectively). Mammography and breast echo were not reliable for differentiating PTs from fibroadenomas (6.9% vs. 37.9% and 3.3% vs. 45%, respectively). Frozen section was of limited value (41.6%). The role of adjuvant radiotherapy and chemotherapy remains to be defined. Local excision, wide excision, or mastectomy with negative surgical margins yielded high local control rates (88.7%, 88.2%, and 100%, respectively), but local excision was associated with a relatively high percentage of positive surgical margins (18.3%). A total of 42 modified radical mastectomies were performed. The reasons for these procedures included a diagnosis of malignancy on frozen section or because the tumors were so large, they were assumed to be carcinomas. No axillary lymph node metastases were found. Fifteen patients in our series had tumors with infiltrating tumor margin, severe stromal overgrowth, atypia, and cellularity. All three patients with metastases (3/15) were in this group. Presence of metastases was significantly correlated with this group (P = 0.0000038). CONCLUSIONS: Wide excision with a clear margin may be the preferable initial therapy, even for malignant PTs. Routine axillary lymph node dissection is not recommended. Patients have tumors with infiltrating tumor margin, severe stromal overgrowth, atypia, and cellularity are at high risk for metastases.


Subject(s)
Breast Neoplasms/surgery , Mastectomy/methods , Phyllodes Tumor/surgery , Adolescent , Adult , Aged , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Child , Female , Humans , Mastectomy, Segmental , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/epidemiology , Phyllodes Tumor/epidemiology , Phyllodes Tumor/pathology , Retrospective Studies , Taiwan/epidemiology , Treatment Outcome
19.
World J Gastroenterol ; 11(24): 3794-6, 2005 Jun 28.
Article in English | MEDLINE | ID: mdl-15968742

ABSTRACT

Carcinoid tumors have been reported in a wide range of organs but most frequently involve the gastrointestinal tract; however, duodenal carcinoid tumors are rare. We report a 50-year-old male patient complaining of multiple melenas for 3 wk. The panendoscopy and endoscopic retrograde cholangiopancreaticography revealed swelling accessory papilla with an ulcer. The biopsy taken showed a carcinoid tumor. The lesion was removed by wide resection. Patient was found to have an abnormal blood cell count during the follow-up period with elevated levels of hemoglobin and hematocrit of 21.2 g/dL and 63.5%, respectively, thrombocytosis of 501,000/microL, and leukocytosis of 20,410/microL. He was diagnosed as a polycythemia vera by a hematologist after further evaluation. He received periodic phlebotomy and hydroxyurea treatment. The response was good and his hematocrit was stabilized by periodic phlebotomy in the range of 44-49% during the last 2 years. The possible origin of UGI bleeding by a duodenal carcinoid tumor, although rare, should be considered. There has been one case report of a duodenal carcinoid tumor that involved accessory papilla of the pancreas divisum and one case report of metastatic carcinoid tumor associated with polycythemia vera. It is different in our patient as compared with the latter report, which mentioned a polycythemia vera patient who was found to have a metastatic carcinoid in the 17 years follow-up period. Chemotherapy had been given before the carcinoid tumor was revealed. Our patient had no previous chemotherapy for polycythemia vera before he was found to have duodenal carcinoid tumor; this excludes the possibility of chemotherapy induced carcinoid tumor, although it had been suspected in the previous report. In our patient, the existence of both diseases may be by predisposition of each other since both diseases have an increased incidence of other neoplasm, or they may be coexistent incidentally.


Subject(s)
Carcinoid Tumor/complications , Duodenal Neoplasms/complications , Pancreatic Ducts/pathology , Polycythemia Vera/complications , Carcinoid Tumor/pathology , Duodenal Neoplasms/pathology , Humans , Male , Middle Aged
20.
ANZ J Surg ; 74(11): 964-7, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15550084

ABSTRACT

BACKGROUND: Choledochal cysts are rare anomalies of the biliary tree and their presentation in adults is infrequent. The high incidence of associated anomalous pancreaticobiliary duct junction (APBDJ) has been well documented. However, the prevalence of APBDJ in different anatomic distribution of cysts has yet to be clarified. METHODS: A total 39 adult patients with choledochal cysts were consecutively enrolled: 22 patients had Todani type I cysts, 16 patients had type IVa cysts, and one patient had a type IVb cyst. RESULTS: No statistical differences were found in age, sex or manifestations. A higher frequency of associated APBDJ was identified in patients with type IVa cyst (100%) than those with type I cyst (P < 0.05). With a mean follow-up of 7.2 years after cyst excision, three patients with type I choledochal cyst and four with type IVa cyst have had episodes of recurrent cholangitis, all accompanied with preoperatively diagnosed APBDJ. CONCLUSION: Anomalous pancreaticobiliary duct junction has a close relationship with adult choledochal cysts, particularly type IVa. We propose the hypothesis that intrahepatic involvement results from progressive enzymatic destruction. Adult choledochal cysts in association with APBDJ, with or without intrahepatic component, should be carefully monitored.


Subject(s)
Bile Duct Diseases/etiology , Bile Ducts, Intrahepatic/abnormalities , Choledochal Cyst/complications , Pancreatic Ducts/abnormalities , Adult , Choledochal Cyst/classification , Female , Humans , Male , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...